More than 100 scientists from across the U.S. are receiving special grants to support their research work in finding innovative solutions to fight heart disease and stroke.
MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer | Psychedelic Invest
NEW YORK–(BUSINESS WIRE)–Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders,